JG
PBYI icon

Jefferies Group’s Puma Biotechnology PBYI Stock Holding History

Jefferies Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42,476
Closed -$436K – 1890
2020
Q4 		$436K Buy
42,476
+73
+0.2% +$739 ﹤0.01% 1186
2020
Q3 		$428K Buy
42,403
+18
+0% +$183 ﹤0.01% 1018
2020
Q2 		$442K Sell
42,385
-6
-0% -$62 0.01% 936
2020
Q1 		$358K Buy
42,391
+1,051
+3% +$10.2K ﹤0.01% 1451
2019
Q4 		$362K Buy
41,340
+28,451
+221% +$236K ﹤0.01% 1986
2019
Q3 		$139K Buy
+12,889
New +$139K ﹤0.01% 2450
2019
Q2 		– Sell
-50,600
Closed -$1.96M – 2795
2019
Q1 		$1.96M Buy
50,600
+49,200
+3,514% +$1.5M 0.02% 921
2018
Q4 		$28K Sell
1,400
-800
-36% -$24K ﹤0.01% 2067
2018
Q3 		$101K Hold
2,200
– – ﹤0.01% 2221
2018
Q2 		$130K Buy
+2,200
New +$127K ﹤0.01% 2102
2014
Q3 		– Sell
-21,488
Closed -$1.42M – 2359
2014
Q2 		$1.42M Buy
+21,488
New +$1.53M 0.01% 765

Other funds holding PBYI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jefferies Group's PBYI Position: Q1 2021 in Review

Jefferies Group sold out of Puma Biotechnology (PBYI) in Q1 2021, closing a stake of 42,476 shares — an estimated $436K sold.

Jefferies Group first reported a position in PBYI in Q2 2014 and held it in 11 quarters. The position peaked at $1.96M in Q1 2019. 118 funds tracked by Wall St. Rank hold PBYI as of Q1 2021.

  • Jefferies Group reported no remaining Puma Biotechnology position as of Q1 2021 after selling out during the quarter.
  • Jefferies Group sold 42,476 Puma Biotechnology shares in Q1 2021, an estimated $436K.
  • Jefferies Group first reported a position in Puma Biotechnology in Q2 2014 and held it in 11 quarters.
  • Jefferies Group's Puma Biotechnology position peaked at $1.96M in Q1 2019.
  • 118 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.